HL7 Australia Implementation Guide:
This page is part of the RCPA Cancer Protocols IG (v0.1.0: Release 1 Draft) based on FHIR R3. . For a full list of available versions, see the Directory of published versions 
The response of the tumour to neoadjuvant treatment must be recorded.
Copyright Statement: This value set includes content from SNOMED CT, which is copyright © 2002+ International Health Terminology Standards Development Organisation (IHTSDO), and distributed by agreement between IHTSDO and HL7. Implementer use of SNOMED CT is not covered by this agreement
This value set includes codes from the following code systems:
This value set contains 7 concepts
All codes from system http://fhir.hl7.org.au/fhir/rcpa/CodeSystem/response-to-neoadjuvant-therapy
| Code | Display | Definition |
| not_applicable | Not applicable | Not applicable |
| uncertain | Uncertain if this is applicable | Uncertain if this is applicable |
| no_prior_treatment | No prior treatment | No prior treatment |
| grade_0 | Grade 0 (complete response) No viable cancer cells | Grade 0 (complete response) No viable cancer cells |
| grade_1 | Grade 1 (moderate response) Single cells or small groups of cancer cells | Grade 1 (moderate response) Single cells or small groups of cancer cells |
| grade_2 | Grade 2 (minimal response) Residual cancer outgrown by fibrosis | Grade 2 (minimal response) Residual cancer outgrown by fibrosis |
| grade_3 | Grade 3 (poor response) Minimal or no tumour kill; extensive residual cancer | Grade 3 (poor response) Minimal or no tumour kill; extensive residual cancer |
© ADHA/HL7 Australia 2014+. Based on FHIR (v) generated on .
|
Propose a change 